Results 161 to 170 of about 3,492,883 (216)

Targeting the tumor-promoting microenvironment in MET-amplified NSCLC cells with a novel inhibitor of pro-HGF activation [PDF]

, 2017
Galemmo, Robert A, Jr, Han, Zhenfu, Janetka, James W, Klampfer, Lidija, Owusu, Benjamin Y, Thomas, Shantasia, Venukadasula, Phanindra   +6 more
core   +2 more sources

Retraction: MiR-148a agomir based targeting of c-Met and Her-3 is able to attenuate EGFR-T790M mutation driven gefitinib and erlotinib resistance in non-small cell lung cancer cells. [PDF]

RSC Adv, 2021
Fisher L.
europepmc   +1 more source

Prognostic significance of calcium-related genes in lung adenocarcinoma and the role of <i>TNNC1</i> in macrophage polarization and erlotinib resistance. [PDF]

Front Immunol
Feng J, Chen Z, Wang G, Yao Y, Min X, Luo J, Xie K.   +6 more
europepmc   +1 more source

Mesenchymal stem cells promote erlotinib resistance in non-small cell lung cancer through the HGF-AKT/ERK1/2-OPN pathway. [PDF]

Am J Transl Res
Yang Y, He J, Long F, Liu Y, Lin L, Wei H.   +5 more
europepmc   +1 more source

The long non-coding RNA CCAT1 promotes erlotinib resistance in cholangiocarcinoma by inducing epithelial-mesenchymal transition via the miR-181a-5p/ROCK2 axis. [PDF]

Am J Cancer Res
Zhou W, Li X, Zhang B, Peng H, Quan C, Xiao X, Luo M, Huang Y, Xu D, Huang K, Jin Q, Lu S.   +11 more
europepmc   +1 more source

Dramatic Response to Teriprilumab and Anlotinib Combination Therapy in a patient with EGFR-Mutant Lung Adenocarcinoma Who Experienced Small-Cell Transformation-Mediated Erlotinib Resistance After Failure of Chemotherapy. [PDF]

JTO Clin Res Rep, 2020
Zhou Y, Zeng L, Yang N, Zhang Y.
europepmc   +1 more source

Correction to "Increased Expression of miR-641 Contributes to Erlotinib Resistance in Non-Small-Cell Lung Cancer Cells by Targeting NF1". [PDF]

Cancer Med
europepmc   +1 more source

Nano-Enabled Fluorescence Switching: A Novel Strategy for PDGFRβ Detection and TKI Therapy Monitoring. [PDF]

Research (Wash D C)
Fu X, Fan J, Chen H, Zheng Y, Liu Y, Zhang C, Cao X, Zuo T.   +7 more
europepmc   +1 more source

TRIPODD Enables Single-Cell Quantification of Therapeutic Efficacy. [PDF]

Mol Pharm
McMahon NP, Solanki A, Montaño AR, Ozdemir ES, Samkoe KS, Tichauer KM, Wang LG, Gibbs SL.   +7 more
europepmc   +1 more source

HIF-1α siRNA Enhances the Efficacy of Erlotinib in Non-small Cell Lung Cancer: A Novel Strategy to Reverse Hypoxia-Induced Drug Resistance. [PDF]

Drugs R D
Jiang H, Cai S, Zhang X, Chen S, Yue C, Yin W, Hu Y.   +6 more
europepmc   +1 more source